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Introduction: Dengue and leptospirosis are two febrile illnesses of great clinical and epidemiological 
importance in Brazil. Their significant degree of symptomatic similarity makes clinical diagnosis difficult.
Objective: To diagnose leptospirosis differentially in patients with clinically suspected dengue.
Materials and methods: In this study, 86 patients with clinically suspected dengue underwent virological 
and serological diagnostic evaluations for dengue (reverse transcriptase polymerase chain reaction, 
NS1 immunochromatographic test, and NS1 enzyme-linked immunosorbent assay, ELISA), as well 
as tests to detect immunoglobulin M (IgM; IgM/IgG Rapid Test and IgM ELISA). The same patients 
were subsequently evaluated for leptospirosis using Rapid Test IgG/IgM (Bioeasy®) and Leptospira IgM 
ELISA (PanBio®).
Results: Of the 86 patients, 48 (55.8%) had positive results for dengue in at least one of the tests and 
five (7.35%) showed positive reactions for leptospirosis.
Conclusion: During dengue epidemics, this disease may be misdiagnosed as other infections, including 
leptospirosis, when diagnosis is based on nonspecific clinical and laboratory criteria alone.
Key words: Leptospirosis; dengue; differential diagnosis; reverse transcriptase polymerase chain 
reaction; enzyme-linked immunosorbent assay.
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Evidencia serológica de leptospirosis en pacientes con sospecha clínica de dengue en el estado 
de Ceará, Brasil
Introducción. El dengue y la leptospirosis son dos enfermedades febriles de gran importancia clínica 
y epidemiológica en Brasil, y presentan una similitud sintomatológica significativa, lo cual dificulta el 
diagnóstico clínico.
Objetivos. Hacer el diagnóstico diferencial para leptospirosis en pacientes con sospecha clínica 
de dengue.
Materiales y métodos. En este estudio, 86 pacientes con sospecha clínica de dengue fueron sometidos 
a examen para el diagnóstico de dengue mediante pruebas de virología y serología (RT-PCR, prueba 
de inmunocromatografía NS1 y ELISA-NS1) y pruebas para la detección de IgM (prueba rápida IgM/
IgG y ELISA-IgM). En los mismos pacientes también se evaluó la presencia de leptospirosis mediante 
la prueba rápida IgG/IgM (Bioeasy®) y ELISA IgM-Leptospira (PanBio®).
Resultados. De los 86 pacientes, 48 (55,8 %) fueron positivos para dengue en, por lo menos, una de 
las pruebas y 5 (7,35 %) presentaron reacciones positivas para leptospirosis.
Conclusión. Durante las epidemias de dengue, otras infecciones y entre ellas la leptospirosis, pueden 
dar lugar a confusiones cuando se el diagnóstico se hace únicamente con base en criterios inespecíficos 
clínicos y de laboratorio.
Palabras clave: leptospirosis, dengue, diagnóstico diferencial, reacción en cadena de la polimerasa 
con transcriptasa inversa, ensayo de inmunoadsorción enzimática.
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Dengue fever is the most prevalent arboviral dis-
ease; it has a widespread global distribution and 
occurs in both tropical and subtropical areas. This 
disease most often occurs during the rainy season 
and may cause various clinical manifestations that 
range from asymptomatic infections to more severe 
conditions. The initial phase of dengue is generally 
characterized by an acute febrile syndrome (fever, 
adynamia, headache, retro-orbital pain, myalgia and 
arthralgia), without symptoms or focal signs (1-3). 
Brazil has a high number of dengue fever cases 
and has already experienced several epidemics. 
The state of Ceará, located in the northeastern 
region, reports thousands of cases of the disease 
each year, the largest epidemics having occurred 
in 1994, 2008, 2011 and 2012 (4,5). Dengue has a 
wide clinical spectrum and, in some cases, it may 
be difficult to differentiate it from other infections 
based solely on clinical-epidemiological criteria. 
Specific laboratory techniques are therefore 
needed for diagnosis. In dengue-endemic regions, 
it is essential to perform a differential diagnosis to 
differentiate it from other febrile syndromes such 
as leptospirosis (1,6).
Leptospirosis is an infectious febrile disease caused 
by pathogenic spirochetes of the genus Leptospira. 
Infections may be asymptomatic, mild or severe 
and acute or chronic (7-9). Notification of cases of 
leptospirosis has been mandatory in Ceará since 
1995 (10). Although this disease is one of the most 
widespread global zoonoses, reliable data on its 
incidence and prevalence in humans are scarce, 
mainly because it is difficult to diagnose. Although 
the microagglutination test (MAT) is the laboratory 
test of choice and is considered to be the standard 
test for leptospirosis, it is time-consuming and 
requires expensive equipment, specialized training 
and use of live Leptospira spp. cultures (11).
Due to the high number of cases of dengue in 
particular and the similarity of its symptoms to 
those of leptospirosis, some studies have shown 
that diagnostic confusion between these diseases 
may occur in routine clinical practice in many areas, 
including Ceará (12). A method for differential 
diagnosis of these infections is needed since the two 
pathologies require different, specific treatments. 
The objective of the present study was, therefore, 
to perform differential diagnosis of leptospirosis in 
patients with clinical suspicion of dengue.
Materials and methods
We conducted a prospective observational study 
between February and December, 2010. The source 
population consisted of patients aged at least 18 
years who had sought treatment in the emergency 
ward of a local hospital. The inclusion criteria for 
the study were: Presence of up to five days of 
fever with no obvious focal source associated 
with two of the following symptoms: adynamia, 
headache, retro-orbital pain, arthralgia, myalgia or 
exanthema. A suspected dengue case is defined 
by the Brazilian Ministry of Health as follows: Acute 
febrile illness accompanied by at least two of the 
following symptoms: headache, retro-orbital pain, 
myalgia, arthralgia, prostration and/or rash. 
Each of the patients selected underwent an 
initial clinical evaluation and blood samples were 
collected for serological and virological tests. The 
blood samples were collected in two steps; the first 
sample was obtained during the first five days of 
fever for use in a specific dengue test (virological 
test; One Step RT-PCR, Qiagen®, USA), dengue 
virus NS1 glycoprotein detection (Dengue NS1 Ag 
strip rapid test, Bio-Rad®, France) and enzyme-
linked immunosorbent assay (ELISA) NS1 
(Bioeasy®, Brazil). Genetic material was extracted 
according to the manufacturer’s instructions 
(Qiagen®) and genomic amplification performed 
using the primers described by Lanciotti, et al. 
(1992) (13). The RT-PCR was carried out using a 
Mastercycler® personal thermocycler (Eppendorf 
®). To visualize the amplified fragments, 10 μl of 
reaction product, 3 μl of running buffer and 2 μl 
of Gel RedTM dye were loaded onto an agarose 
gel (Sigma, St. Louis, USA) and subjected to 
horizontal electrophoresis (60 V/h), with gels 
being visualized under UV illumination. 
The second blood sample was collected when 
the patient returned to the hospital during the 
recovery phase, defined as the period following 
the fifth day of symptoms, to undergo serological 
tests (Dengue duo test; Bioeasy®), a dengue ELISA 
immunoglobulin M assay (IgM; Bioeasy®), anti-
Leptospira (IgG/IgM rapid test for leptospirosis; 
Bioeasy®) and Leptospira IgM ELISA (PanBio®, 
Australia). 
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All patients were initially subjected to tests to identify 
dengue infections. Given the high prevalence of 
this infection in the region, several techniques were 
employed for virological and serological detection. 
After being tested for dengue, samples were also 
analyzed for leptospirosis. Epidemiological, clinical, 
and nonspecific laboratory data were collected 
from all patients in the study and entered onto a 
standardized datasheet. Patients were defined 
as dengue cases based on clinical, virological 
and serological criteria; thus, all cases positive for 
reverse transcriptase polymerase chain reaction 
(RT-PCR) and/or IgM and/or NS1 expression were 
considered to have dengue. The present study 
had a descriptive cross-sectional design and was 
approved by the Research Ethics Committee of the 
São José Hospital of Infectious Diseases, Fortaleza 
(protocol No. 064/2009).
Results
Of the 86 patients evaluated with clinical suspicion 
of dengue, 48 (55.8%) were positively confirmed 
as having dengue in at least one of the laboratory 
tests performed. Among these patients, 23 
(47.9%) were positive for dengue by the ELISA-
NS1, 14 (29.1%) by the NS1 rapid test (Dengue 
NS1 Ag Strip), 16 (33.3%) by RT-PCR, 38 (79.1%) 
by the ELISA-IgM and 36 (75%) by the IgM rapid 
test (Dengue Duo Test). Five patients (5.8%) with 
a clinical suspicion of dengue had positive results 
in the leptospirosis test and all showed positive 
results for ELISA-IgM showing titers ≥1:100, 
whereas only one patient (1.16%) was diagnosed 
with dengue through the rapid test. Thirty-five 
patients (40.6%) remained without a specific 
laboratory diagnosis and were classified as having 
undifferentiated febrile syndrome. 
The main clinical findings among the patients with 
leptospirosis were fever (5/5; 100%), prostration 
(5/5; 100%), headache (4/5; 80%), myalgia (4/5; 
80%), arthralgia (3/5; 60%), retro-orbital pain (2/5; 
40%) and exanthema (1/5; 20%). In addition to 
these common symptoms of dengue, the patients 
also reported anorexia (5/5; 100%), nausea (3/5, 
60%), vomiting (2/5, 40%), diarrhea (2/5, 40%) and 
coughing (2/5, 40%). The following abnormalities 
were found among the nonspecific laboratory 
test findings: low hemoglobin (<11.6 g/dl) and 
hematocrit levels (<36%) in three patients (60%), 
thrombocytopenia (<150,000/mm3) in two patients 
(40%), lymphopenia (<20%) in three patients (60%), 
elevated aspartate aminotransferase (>40 U/L) and 
alanine aminotransferase levels (>40 U/L) in three 
patients (60%) and mild leukocytosis (>11,000/
mm3) in one patient (20%) (table 1).
Among the five patients positive for leptospirosis, two 
showed specific laboratory diagnoses for both this 
and dengue (table 2). The two patients with positive 
results for both infections were female outpatients 
with fever, myalgia, prostration and arthralgia. We 
used a numerical code to preserve anonymity. 
Patient one had no abnormalities in the nonspecific 
tests, whereas patient three showed low hemoglobin 
(<11.6 g/dl) and hematocrit levels (<36%).
Discussion
The clinical features of leptospirosis can be 
confused with those of dengue, especially during 
epidemic periods of the latter, when diagnosis can 
only be confirmed by clinical and epidemiological 
criteria (6,14). Brown, et al., assessed 590 patients 
suspected of dengue infection of whom 314 showed 
positive results for serological tests for dengue and 
27 were positive for leptospirosis (14). In this study, 
five (5.8%) of the 86 patients with clinical suspicion 
of dengue were positive for leptospirosis. Although 
the number of patients with leptospirosis was small, 
our results corroborate those of Brown, et al.’s 
study. The leptospirosis-positive results of the five 
patients with initial suspicion of dengue suggested 
that, in the state of Ceará, confusion in clinical 
diagnosis might be occurring due to the similarity 
Table 1. Nonspecific laboratory test results of the patients with leptospirosis
Nonspecific laboratory tests Case 1 Case 2 Case 3 Case 4 Case 5
Hemoglobin (11.5-16.4 g/dl)
Hematocrit (36.0-48.0%)
Platelets (150,000-450,000/mm3)
Leukocytes (3,600-11,000/mm3)
Lymphocytes (20-50%)
AST (<40 U/L)
ALT (<40 U/L)
12.8
38.4 
215,000 
3,630 
27 
14 
14 
10.9* 
32.3*
76,000*
7,160
11*
100*
81*
9.6*
29.4*
201,000
6,760
32
20
15
12.3
36.7
196,000
11,250*
8*
129*
57*
9.2*
31.5*
66,000*
9,900
30
154*
84*
AST: Aspartate amino-transaminase; ALT: Alanine amino-transaminase
*: Altered results
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of the symptoms of these two diseases. Our data 
support the findings of Oliveira, et al., who reported 
cases of leptospirosis during a dengue epidemic 
in Ceará. In the present study, although no other 
diagnostic tests for leptospirosis were performed, 
we considered patients who were positive for the 
ELISA-IGM to be probable cases of leptospirosis. 
We wish to emphasize that it is not possible to 
categorically state that this result confirms an 
active infection. Unfortunately, additional collections 
were not carried out to evaluate seroconversion 
and other diagnostic tests were not performed 
because standardized PCR and MAT execution 
were lacking, representing a limitation of our study. 
However, published articles suggest that patients 
can test positive for leptospirosis using only IgM 
detection (12,14).
The tests most commonly used for the laboratory 
diagnosis of leptospirosis in Brazil are ELISA-IgM 
and MAT (Brazil, 2010) (15). Recently, the use of 
ELISA tests has increased because of the various 
difficulties in conducting the MAT. In addition, 
immunoenzymatic assays can detect IgM at an 
early stage and have high degrees of sensitivity 
and specificity. New tests are also being devel-
oped, such as immunochromatographic assays, 
which have provided good results for IgM detection 
(16-18).
IgM antibodies are present from the third day of 
leptospirosis infection and may persist for up to 
five months (18). All of our samples were collected 
between the fifth and tenth days after onset of 
symptoms and were thus within the period during 
which IgM antibodies are present, allowing both 
tests to be used for detection. The ELISA showed 
higher positivity than the immunochromatographic 
tests, detecting anti-Leptospira antibodies in five 
patients. Sehgal, et al., reported that the immuno-
chromatographic test showed a positivity rate similar 
to that of the immunoenzymatic assay, in contrast 
to the results obtained in the present study (19). 
However, Blacksell, et al., indicated that the rapid 
test showed low positivity when compared with 
the ELISA, corroborating our data (19). Cohen, et 
al., suggested that immunochromatographic tests 
showed good positivity only when conducted during 
the convalescence phase. These authors also 
recommended re-testing patients with continued 
symptoms if the first test result was negative (20).
The symptomatology of patients positive for lepto-
spirosis corroborates the findings of Daher, et al., 
although jaundice was not observed in the present 
study. These authors reported that patients with 
leptospirosis presented fever (96.5%), headache 
(74.6%), myalgia (92.5%), jaundice (94.5%), 
vomiting (71.6%), dehydration (63.5%) and chills 
(62.2%) (21). It is worth emphasizing that of the five 
patients who were positive for leptospirosis, three 
were hospitalized, where they probably developed 
some of the most severe forms of leptospirosis. 
The most frequent laboratory abnormalities in the 
patients with leptospirosis were thrombocytopenia, 
leukocytosis and transaminase elevation, as well 
as low hematocrit and hemoglobin levels (21). 
These abnormalities were also observed in the 
present study.
The simultaneous occurrence of two or more 
infections is not rare and presents challenging 
clinical features. The therapeutic options and 
prognoses of patients can be similarly complex 
(22). Some studies have shown that co-infection 
with dengue and leptospirosis is possible, which 
re-emphasizes the need for specific diagnostics for 
both diseases (23-25). In our study, patients 1 and 
3 tested positive for both dengue and leptospirosis. 
However, detection of one of the etiologies using 
a specific test was only observed in patient 1 by 
confirming the presence of the dengue antigen 
through RT-PCR, although anti-dengue antibodies 
were not detected. Thus, because both patients 
were positive for serological tests alone and these 
antibodies may remain in circulation for a prolonged 
period, we could not differentiate between potential 
co-infections and sequential infections. The IgM 
antibodies for dengue and leptospirosis generally 
remain in circulation for prolonged periods of 
three or five months respectively, hindering the 
classification of disease as recent or current (26). 
However, Behera, et al., considered a patient 
who was positive for the ELISA to be a case of 
co-infection, showing anti-dengue and anti-
Leptospira antibodies (27). Thirty-five patients 
remained without a specific laboratory diagnosis, 
suggesting that they had been infected by other 
Table 2. Patients positive for dengue and leptospirosis 
concomitantly
Specific diagnosis
Case RT-PCR
Dengue
ELISA-IgM
Dengue
ELISA-IgM
Leptospirosis
1
3
Positive
Negative
Negative
Positive
Positive
Positive
ELISA: Enzyme-linked immunosorbent assay
RT-PCR: Reverse transcriptase-polymerase chain reaction
IgM: Immunoglobulin M
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infectious agents causing clinical features similar 
to those of dengue; they may also have been 
infected by the agents studied here, although 
these were not detectable with the techniques 
used. Several studies have reported diagnostic 
confusion between dengue and other pathologies 
such as hantavirus, rubella, hepatitis, influenza A 
virus, and melioidosis (28-30).
In this study, we identified patients with a 
clinical suspicion of dengue who were positive 
for leptospirosis, demonstrating that diagnostic 
confusion may occur between these diseases 
and underlining the need for specific laboratory 
techniques for the diagnosis of these pathologies. 
We recognize, however, that this study presents 
some limitations, such as the absence of paired 
samples. Anti-Leptospira IgM antibodies can be 
detected for months after initial contact with the 
antigen and we therefore cannot confirm that 
the patients had active infections. Nevertheless, 
this study provides a strong indication that cases 
of leptospirosis are likely to be confused with 
dengue infections. 
The results reported here demonstrate the need 
for differential diagnosis of dengue, in particular 
in regions that report dengue epidemics; due to 
similarity of symptoms with other pathologies, cases 
of other diseases may be underreported. Thus, it 
is essential to perform additional studies on more 
efficacious tests for the laboratory diagnosis of both 
infections. Accurate and early diagnosis is critical 
in clinical practice, as the appropriate treatments 
for patients with dengue and leptospirosis are quite 
different. In addition, epidemiological surveillance 
and control measures can only be performed 
correctly when the real infectious agent is known. 
More efficient diagnostic tests for these infections 
are therefore needed.
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